Massimiliano Agostini
Università degli Studi di Roma Tor Vergata
H-index: 46
Europe-Italy
Top articles of Massimiliano Agostini
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Molecular profiling of a bladder cancer with very high tumour mutational burden | Cell Death Discovery | Manuel Scimeca Julia Bischof Rita Bonfiglio Elisabetta Nale Valerio Iacovelli | 2024/4/30 |
Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype | Discover Oncology | Mengting Zhu Valentina Rovella Manuel Scimeca Alessandro Mauriello Yufang Shi | 2024/12 |
Apoptotic cell death in disease—Current understanding of the NCCD 2023 | Ilio Vitale Federico Pietrocola Emma Guilbaud Stuart A Aaronson John M Abrams | 2023/5 | |
ZFP750 affects the cutaneous barrier through regulating lipid metabolism | Science Advances | Alessio Butera Massimiliano Agostini Matteo Cassandri Francesca De Nicola Maurizio Fanciulli | 2023/4/28 |
Alleviating hypoxia to improve cancer immunotherapy | Peng Fan Naidong Zhang Eleonora Candi Massimiliano Agostini Mauro Piacentini | 2023/12/1 | |
ZNF750: A novel prognostic biomarker in metastatic prostate cancer | International Journal of Molecular Sciences | Manuela Montanaro Massimiliano Agostini Lucia Anemona Elena Bonanno Francesca Servadei | 2023/3/30 |
Macrophage polarization and metabolism in atherosclerosis | Pengbo Hou Jiankai Fang Zhanhong Liu Yufang Shi Massimiliano Agostini | 2023/10/20 | |
Harnessing metabolism of hepatic macrophages to aid liver regeneration | Rui Liu Manuel Scimeca Qiang Sun Gerry Melino Alessandro Mauriello | 2023/8/29 | |
Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy | Manuel Scimeca Valentina Rovella Valeria Palumbo Maria Paola Scioli Rita Bonfiglio | 2023/7/15 | |
Correction to: The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome | Oncogene | Francesco Rugolo Nicolas G Bazan Jorgelina Calandria Bokkyoo Jun Giuseppe Raschellà | 2022/2/25 |
Long non-coding RNAs affecting cell metabolism in cancer | Massimiliano Agostini Mara Mancini Eleonora Candi | 2022/10/1 | |
Targeting lipid metabolism in cancer: neuroblastoma | Massimiliano Agostini Gerry Melino Bola Habeb Jorgelina M Calandria Nicolas G Bazan | 2022/6 | |
TAp63 regulates bone remodeling by modulating the expression of TNFRSF11B/Osteoprotegerin | Cell Cycle | Anna Maria Lena Erica Foffi Massimiliano Agostini Mara Mancini Margherita Annicchiarico-Petruzzelli | 2021/11/17 |
The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome | Oncogene | Francesco Rugolo Nicolas G Bazan Jorgelina Calandria Bokkyoo Jun Giuseppe Raschellà | 2021/9/23 |
Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin | Cell Death & Differentiation | Tania Velletri Yin Huang Yu Wang Qing Li Mingyuan Hu | 2021/1 |
Regulation of adult neurogenesis in mammalian brain | Maria Victoria Niklison-Chirou Massimiliano Agostini Ivano Amelio Gerry Melino | 2020/7/9 | |
The C terminus of p73 is essential for hippocampal development | Proceedings of the National Academy of Sciences | Ivano Amelio Emanuele Panatta Maria Victoria Niklison-Chirou Joern R Steinert Massimiliano Agostini | 2020/7/7 |
ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes | Oncogene | Matteo Cassandri Alessio Butera Ivano Amelio Anna Maria Lena Manuela Montanaro | 2020/5/28 |
The role of noncoding RNAs in epithelial cancer | Massimiliano Agostini Carlo Ganini Eleonora Candi Gerry Melino | 2020/3/12 | |
The ZNF750–RAC1 axis as potential prognostic factor for breast cancer | Cell Death Discovery | Alessio Butera Matteo Cassandri Francesco Rugolo Massimiliano Agostini Gerry Melino | 2020/11/29 |
Co-Authors
